Gupta Akanksha, Berg David T, Gerlitz Bruce, Sharma Ganesh R, Syed Samreen, Richardson Mark A, Sandusky George, Heuer Josef G, Galbreath Elizabeth J, Grinnell Brian W
Biotechnology Discovery Research, Eli-Lilly Research Laboratories, Lilly Corporate Center, 355 East Merrill Street, DC# 0434, Lilly & Company, Indianapolis, Indiana 462225, USA.
J Am Soc Nephrol. 2007 Mar;18(3):860-7. doi: 10.1681/ASN.2006101167. Epub 2007 Feb 14.
Protein C (PC) plays an important role in vascular function, and acquired deficiency during sepsis is associated with increased mortality in both animal models and in clinical studies. This study explored the consequences of PC suppression on the kidney in a cecal ligation and puncture model of polymicrobial sepsis. This study shows that a rapid drop in PC after sepsis is strongly associated with an increase in blood urea nitrogen, renal pathology, and expression of known markers of renal injury, including neutrophil gelatinase-associated lipocalin, CXCL1, and CXCL2. The endothelial PC receptor, which is required for the anti-inflammatory and antiapoptotic activity of activated PC (APC), was significantly increased after cecal ligation and puncture as well as in the microvasculature of human kidneys after injury. Treatment of septic animals with APC reduced blood urea nitrogen, renal pathology, and chemokine expression and dramatically reduced the induction of inducible nitric oxide synthase and caspase-3 activation in the kidney. The data demonstrate a clear link between acquired PC deficiency and renal dysfunction in sepsis and suggest a compensatory upregulation of the signaling receptor. Moreover, these data suggest that APC treatment may be effective in reducing inflammatory and apoptotic insult during sepsis-induced acute renal failure.
蛋白C(PC)在血管功能中发挥着重要作用,在脓毒症期间获得性缺乏与动物模型和临床研究中的死亡率增加相关。本研究在多微生物脓毒症的盲肠结扎和穿刺模型中探讨了PC抑制对肾脏的影响。本研究表明,脓毒症后PC的快速下降与血尿素氮升高、肾脏病理改变以及肾损伤已知标志物的表达增加密切相关,这些标志物包括中性粒细胞明胶酶相关脂质运载蛋白、CXCL1和CXCL2。活化蛋白C(APC)的抗炎和抗凋亡活性所需的内皮PC受体,在盲肠结扎和穿刺后以及人类肾脏损伤后的微血管中显著增加。用APC治疗脓毒症动物可降低血尿素氮、改善肾脏病理改变并减少趋化因子表达,还能显著降低肾脏中诱导型一氧化氮合酶的诱导和半胱天冬酶-3的激活。数据表明脓毒症中获得性PC缺乏与肾功能障碍之间存在明确联系,并提示信号受体的代偿性上调。此外,这些数据表明APC治疗可能有效减轻脓毒症诱导的急性肾衰竭期间的炎症和凋亡损伤。